Delivery Order SPE2DB22D2206-SPE2DB25FEA18

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,868.49, is a Firm Fixed Price Delivery Order for the supply of INFUVITE ADULT BULK VIAL 100ML medical products. The award has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with a ceiling value of $39,014.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of INFUVITE ADULT BULK VIAL 100ML medical products to the Defense Logistics Agency (DLA). The $31,366.97 delivery order is placed under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the company's primary vehicle for providing a wide range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $12,655.78 firm fixed-price delivery order is for the provision of INFUVITE ADULT VIAL 10ML medical supplies, with a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of INFUVITE ADULT BULK VIAL 100ML medical products. The contract has a ceiling value of $19,288.02 and a period of performance through October 22, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,126.15 Firm Fixed Price delivery order contract is for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 4, 2025. The $8,014.00 firm-fixed-price delivery order is for the supply of INFUVITE PEDIATRIC VIAL 5ML medical products. The contract has an ultimate completion date of February 5, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,348.42 contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The award has an ultimate completion date of October 28, 2024 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,870.36, is for the delivery of Infuvite Pediatric Vial 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order type, with a completion date of January 22, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award is for the delivery of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,970.10 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract has a performance period through January 26, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA18
    Delivery Order

This federal contract award is for the delivery of INFUVITE ADULT BULK VIAL 100ML pharmaceutical products to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The contract has a ceiling value of $15,191.97 and is a Firm Fixed Price Delivery Order type, with a period of performance through October 31, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for the provision of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs. This particular award was not designated with a set-aside requirement, indicating open competition. The contract supports the medical needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

Generated 1/29/25, 9:26 AM